Related Experiment Video

Updated: Aug 8, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

TRAIL induces apoptosis and activation of NFkappaB

I Jeremias1, K M Debatin

  • 1Universitätskinderklinik, Prittwitzstr. 42, 89075 Ulm, Germany. Tel: (+49) 731 5027700, Fax: (+49) 731 5026681, USA.

European Cytokine Network
|January 16, 1999
PubMed

Insights

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers cancer cell death. Inhibiting NFkappaB enhances TRAIL

Area of Science:

  • Immunology and Cancer Biology: Focus on cell death pathways and molecular signaling in oncology.

Background:

  • Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a key mediator of programmed cell death.
  • TRAIL targets various cancer cells, inducing apoptosis through caspase-dependent pathways.
  • TRAIL signaling also activates NFkappaB, a transcription factor involved in inflammation and cell survival.

Purpose of the Study:

  • To investigate the interplay between TRAIL-induced apoptosis and NFkappaB activation.
  • To determine if modulating NFkappaB activity can enhance TRAIL's anti-cancer effects.

Main Methods:

  • Utilized cell culture models of various malignant cell lines and primary tumor cells.
  • Analyzed TRAIL-induced cell death and apoptosis.
  • Investigated the role of NFkappaB signaling in response to TRAIL treatment.

Main Results:

  • TRAIL effectively induced apoptosis in a broad spectrum of cancer cells.
  • TRAIL activated both caspase-dependent cell death and NFkappaB-mediated gene induction.
  • Inhibition of TRAIL-induced NFkappaB activation significantly augmented TRAIL-mediated apoptosis.
  • Blocking NFkappaB signaling also reduced resistance to TRAIL-induced cell death.

Conclusions:

  • NFkappaB activation acts as a negative regulator of TRAIL-induced apoptosis.
  • Targeting the NFkappaB pathway in conjunction with TRAIL holds therapeutic potential for cancer treatment.
  • Modulating NFkappaB signaling may overcome resistance mechanisms to TRAIL-based therapies.

More Related Videos

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...